Συντηρητικά τροφίμων: Αναγκαία "ασπίδα", αλλά και κρυφοί κίνδυνοι

With lectures from leading endocrine researchers and group breakout sessions to discuss scientific challenges in detail, delegates will benefit from expert education across this broad field.This event is an excellent way to not only grow as a scientist, but to make friends across Europe in the field of endocrinology, with an extensive social programme, including networking, sports and group activities, complementing the outstanding scientific education provided.This is a basic science-focused school, however some translational topics will be covered.  Topics include; adrenals, calcium and bone, diabetes, receptor signaling, endocrine deficiency and more.

On behalf of the Local Organising Committee, we are thrilled to invite you to this premier event in reproductive science and medicine, taking place in London, United Kingdom, from 5 to 8 July 2026.Connect with the brightest minds in reproductive science and medicine, explore groundbreaking innovations, and experience a truly transformative learning event. Don’t miss this opportunity to network, share ideas, and engage with peers from around the world.

Day one | Aetiologies, evidence, research, and ethics Registration from 8.30 am9.30 am Welcoming speech: Baroness Dianne HayterIntroduction Dr Louise Irvine, co-chair CAN-SGHistory and aetiologies Chair: Dr Stella KingettA brief history of gender medicine and the rise of the Dutch protocol (Zhenya Abbruzzese)How the availability of puberty suppression transformed the social, cultural, and medical landscape (Prof. Michael Biggs)Diagnoses in gender medicine (Prof Alex Byrne)Evidence, uncertainty, and riskChair: Dr Louise IrvineDiagnostic, aetiological and prognostic uncertainty in youth gender medicine  (Dr. Alison Clayton)Puberty blockers and the adolescent brain (Prof. Sallie Baxendale)Breaking the Mold: How the American Society of Plastic Surgeons Decided to Put Evidence First (Scot Bradley Glasberg, M.D., former chair of American Plastic Surgery Association)Uncertainty and risk in gender treatments in adults: failings of the UK Levy review. (Dr Louise Irvine)ResearchChair: Prof Alice SullivanBarriers to research in gender medicine (Prof Alice Sullivan)Pathways puberty blocker trial and why it does not comply with UK research regulations Dr. Sinéad Helyar)Is there equipoise for interventional trials? (Dr. Ray Zhang) Adverse effects of hormonal interventions in gender medicine (Dr. Hannah Ryan)Ethics Chair: Zhenya AbbruzzeseWhen evidence is uncertain how do we decide? (Zhenya Abbruzzese)Evidence, Ethics, and Youth Gender Dysphoria (Prof. Moti Gorin)Parent perspective: decision-making on a child’s behalf when evidence is uncertainDay two | Social and cultural contexts, clinical perspectivesBegins 9.30 amSocial and cultural influencesChair Dr David PilgrimSocial transition: what’s the harm? (Stephanie Davies-Arai)Beliefs about medical transition and the body in online trans spaces (Sarah Mittermaier)Detransition pathways: going back but moving forward (Michael Kerr)Child and adolescent mental healthChair: Dr Aileen O’BrienPsychotherapeutic work for embodied distress in adolescence (Anastassis Spiliadis)How can healthcare providers support young people questioning their gender identity, without fear – recent research on psychiatrists and psychologists (Prof. Céline Masson)Clinical perspectives Chair: Dr David BellPsychotherapeutic work with gender-distressed youth (Dr. Anna Hutchinson and Dr Celia Sadie)Helping parents manage their child’s new gender identity (Dr. Stephen Levine)Investigating the link between autism spectrum disorders and gender distress (Dr. Katie Alcock)The role of physiotherapy in managing the unwanted effects of gender interventions, with particular focus on pelvic health conditions.(Elaine Miller)Looking to the future panel discussion: How can we support children, families and young adults? Chair: Sue Evans “How can we support children, families and young adults, going forward?” Panel discussion with Stephanie Davies-Arai, Dr. Anna Hutchinson, Dr Hannah Ryan, Dr. Stephen Levine, Michael Kerr and a parentClosing remarks Dr Stella Kingett, co-chair, CAN-SG

Recent advances in anaerobic microbiology have driven significant progress in biotechnology, environmental microbiology, and biochemistry. Anaerobes play key roles in sustainable biotechnological processes, including biomethanation, chain elongation for bio-based chemicals, and microbial electrosynthesis for carbon-neutral energy production. In environmental microbiology, anaerobes are essential for wastewater treatment, bioremediation, and global biogeochemical cycles, influencing carbon sequestration and greenhouse gas emissions. In biochemistry, anaerobic microbes produce novel enzymes for industrial applications, and biohydrogen production, offering new solutions for green chemistry.Despite their importance, anaerobic microbiology remains underrepresented due to the technical challenges of anoxic cultivation. This EMBO Practical Course directly addresses this gap by providing researchers with essential training in anaerobic cultivation techniques, from fundamental methods to cutting-edge approaches. By integrating both state-of-the-art and low-tech solutions, the course empowers participants to implement anaerobic research in laboratories worldwide, accelerating innovation in biotechnology, environmental sustainability, and biochemical discovery.